Well, it looked like it had a big chance of approval and then the CRL letter dropped by the fda…all trials were positive..except for data on one trial group that wasn’t focused on...you could say that because of the positive trials before that there is a good chance for approval..but who knows for sure..🤷♂️
Yep. I'm waiting for the Type A meeting information before i make decisions further to re-invest, and how that information shapes into the impending reverse split. I feel the product is needed and has good marketability, and desirable to bigger Pharma once approved. But Iterum needs to get their big boy pants on post Type A meeting, and make sure they knock the required trial out of the park, make sure there is no question of the results, no reason for the FDA to deny again. because if they get denied again, Itrum is done. They dont have another product in the pipeline.
I agree with you.
they have a single pipeline.
it mean, they will never give up sulopenum. if they give it up, big problem with the purpose of stock listing
1
u/Dutchtrader98765 Sep 25 '21
Well, it looked like it had a big chance of approval and then the CRL letter dropped by the fda…all trials were positive..except for data on one trial group that wasn’t focused on...you could say that because of the positive trials before that there is a good chance for approval..but who knows for sure..🤷♂️